Kliniska prövningar Nct sida
Clinical Trial Results:
Efficacy of 500µg roflumilast once daily versus placebo over 12 weeks in patients with diabetes mellitus type 2. A double blind, parallel group, phase IIb, proof of concept clinical study
| Summary | |
EudraCT number | 2005-005702-23 |
Trial protocol | DE |
Global completion date | 08 Nov 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 14 Oct 2016 |
First version publication date | 14 Oct 2016 |
Other versions | |
Summary report(s) | BY217/M2-401 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.